Cite
HARVARD Citation
Zhou, L. et al. (2018). Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple‐negative breast cancer cells. Cancer communications. 38 (1), pp. 1-5. [Online].